Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP Sunscreen for Skin Cancer Prevention
NCT05736224Phase 1Completed
- Sponsor
- Yale University
- Start
- May 2023
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial of BNP Sunscreen in skin cancer (2 arms), sponsored by Yale University. Primary endpoints: Cyclobutane Pyrimidine Dimer Measurement at 5 minutes, Cyclobutane Pyrimidine Dimer Measurement at 4 hours and 4 more. Started May 2023; status: completed.
02
Drugs
BNP Sunscreen
03
Conditions
skin cancer
Beyond the preview
Go deeper on NCT05736224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05736224.